George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,956.00
Bid: 11,952.00
Ask: 11,956.00
Change: -70.00 (-0.58%)
Spread: 4.00 (0.033%)
Open: 12,070.00
High: 12,144.00
Low: 11,940.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

19 Dec 2020 00:51

EXPLAINER-Where are we in the COVID-19 vaccine race?

(Adds detail throughout)Dec 27 (Reuters) - European Union gave approval on Dec. 21 for the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, the latest regulatory go-ahead for the shot, while the United States authorised Moderna Inc's vac...

Read more
19 Dec 2020 00:51

EXPLAINER-Where are we in the COVID-19 vaccine race?

Dec 18 (Reuters) - Moderna Inc's COVID-19 vaccine was authorized by U.S. regulators on Friday, the second inoculation against the new coronavirus to get a regulatory green light in the United States and the first approval for Moderna's shot world...

Read more
19 Dec 2020 00:44

UPDATE 8-U.S. authorizes Moderna COVID-19 vaccine, elderly next in line for shots

(Adds comments from president-elect, infectious disease expert)By Michael ErmanDec 18 (Reuters) - Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration,...

Read more
19 Dec 2020 00:44

UPDATE 7-Moderna COVID-19 vaccine gets U.S. authorization, second in 8 days

(Adds age groups approved for vaccination, CDC plans for priority groups)By Michael ErmanDec 18 (Reuters) - Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Admi...

Read more
19 Dec 2020 00:32

Colombia reaches deals with Pfizer, AstraZeneca for COVID-19 vaccines

By Julia Symmes CobbBOGOTA, Dec 18 (Reuters) - Colombia has inked deals with pharmaceutical companies Pfizer and AstraZeneca to provide 20 million doses of COVID-19 vaccines, President Ivan Duque said on Friday.The Andean country topped 40,000 cor...

Read more
18 Dec 2020 21:23

UPDATE 1-UK's Johnson summons ministers over new COVID-19 variant -The Telegraph

(Adds details, background)LONDON, Dec 18 (Reuters) - British Prime Minister Boris Johnson has called senior ministers to an unscheduled meeting on Friday evening to discuss how to contain a new, more virulent variant of the coronavirus, The Telegr...

Read more
18 Dec 2020 19:27

Trump remains willing to take coronavirus vaccine -spokesman

WASHINGTON, Dec 18 (Reuters) - White House Spokesman Brian Morgenstern on Friday said that President Donald Trump remains willing to take the newly approved COVID-19 vaccine when the time is right, noting that Trump has already been infected with ...

Read more
18 Dec 2020 14:50

Trudeau commits Canada to sharing any extra vaccine doses

TORONTO, Dec 18 (Reuters) - Canada will donate COVID-19 vaccines to other countries if it receives more doses than necessary, its Prime Minister Justin Trudeau said in a television interview.Reuters reported in November that Canada was in talks to...

Read more
18 Dec 2020 13:28

UPDATE 1-COVAX programme doubles global vaccine supply deals to 2 billion doses

(Adds details of new agreements)GENEVA, Dec 18 (Reuters) - The COVAX alliance which aims to secure COVID-19 vaccines for the world's most vulnerable people said on Friday it had gained access to nearly 2 billion doses, roughly doubling its supply,...

Read more
18 Dec 2020 13:28

UPDATE 2-COVAX programme doubles global vaccine supply deals to 2 billion doses

* COVAX alliance announces new COVID-19 vaccine agreements* Agreements are now in place for nearly 2 billion doses* WHO chief hails announcement as "fantastic news" (Adds details, quotes, COVAX in talks with Pfizer and Moderna)By Stephanie Nebehay a...

Read more
18 Dec 2020 13:00

COVAX programme doubles global vaccine supply deals to 2 billion doses

Dec 18 (Reuters) - The COVAX alliance which aims to secure COVID-19 vaccines for the world's most vulnerable people said on Friday it had gained access to nearly 2 billion doses, roughly doubling its supply, with the first deliveries expected in t...

Read more
18 Dec 2020 12:02

UK PM Johnson says he hopes to avoid another lockdown for England

LONDON, Dec 18 (Reuters) - British Prime Minister Boris Johnson said on Friday he hoped that England would not need to go into a third lockdown after Christmas and follow Wales and Northern Ireland in imposing the measure to stop the growing spre...

Read more
17 Dec 2020 16:34

UPDATE 1-Oxford says vaccine has good immune response with two-dose regime

(Adds detail, background)LONDON, Dec 17 (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday.The v...

Read more
17 Dec 2020 16:34

UPDATE 2-Early data show two doses of Oxford/AstraZeneca vaccine provoked good immune response

(Adds context)LONDON, Dec 17 (Reuters) - Oxford University's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday, citi...

Read more
17 Dec 2020 16:05

Oxford says vaccine has good immune response with two dose regime

LONDON, Dec 17 (Reuters) - Oxford's COVID-19 vaccine candidate stimulates broad antibody and T cell responses and has the best immune response when a two full-dose regime is used, the university said, citing more detailed early stage trial data.T...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.